J&J COVID بوسٹر ويڪسين هاڻي گرين لائيٽ حاصل ڪري ٿي

           

“Today’s recommendation supports the use of the Johnson & Johnson COVID-19 vaccine as a booster for eligible individuals in the U.S. regardless of which vaccine they initially receive,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. “The Johnson & Johnson vaccine provided 94 percent protection in the U.S. against COVID-19 when given as a booster following the single-shot Johnson & Johnson vaccine, and due to its unique mechanism of action, offers long-lasting, durable protection. We remain confident in the benefit it will provide to millions around the world.”

The Johnson & Johnson COVID-19 vaccine was recommended as a booster for adults aged 18 and older who received the Johnson & Johnson single-shot vaccine at least two months earlier. A booster dose of the Johnson & Johnson COVID-19 vaccine was also recommended for eligible adults at least six months following the second dose of an authorized mRNA vaccine.

The ACIP recommendation has been forwarded to the Director of the CDC and the U.S. Department of Health and Human Services (HHS) for review and adoption.

The Company’s single-dose COVID-19 vaccine received FDA Emergency Use Authorization for adults aged 18 and older on February 27, 2021. On October 20, 2021, the FDA authorized for emergency use a booster shot of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with the Company’s single-dose vaccine.

مجاز استعمال

The Janssen COVID-19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to provide:

•             Primary vaccination regimen for the Janssen COVID-19 Vaccine is a single-dose (0.5 mL) administered to individuals 18 years of age and older.

•             A single Janssen COVID-19 Vaccine booster dose (0.5 mL) may be administered at least 2 months after the primary vaccination to individuals 18 years of age and older.

•             A single booster dose of the Janssen COVID-19 Vaccine (0.5 mL) may be administered as a heterologous booster dose following completion of primary vaccination with another authorized or approved COVID-19 vaccine. The eligible population(s) and dosing interval for the heterologous booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination.

اهم حفاظت جي INFاڻ

WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE YOU GET THE JANSSEN COVID-19 VACCINE?

Tell the vaccination provider about all of your medical conditions, including if you:

•             have any allergies

•             have a fever

•             have a bleeding disorder or are on a blood thinner

•             are immunocompromised or are on a medicine that affects your immune system

•             are pregnant or plan to become pregnant

•             are breastfeeding

•             have received another COVID-19 vaccine

•             have ever fainted in association with an injection

WHO SHOULD NOT GET THE JANSSEN COVID-19 VACCINE?

توهان کي جانسن COVID-19 ويڪسين حاصل نه ڪرڻ گهرجي جيڪڏهن توهان:

•             had a severe allergic reaction after a previous dose of this vaccine

•             had a severe allergic reaction to any ingredient of this vaccine.

HOW IS THE JANSSEN COVID-19 VACCINE GIVEN?

جانسن COVID-19 ويڪسين توهان کي عضلات ۾ انجيڪشن طور ڏني ويندي. 

Primary Vaccination: The Janssen COVID-19 Vaccine is administered as a single dose.

بوسٹر دوز:

•             A single booster dose of the Janssen COVID-19 Vaccine may be administered at least two months after primary vaccination with the Janssen COVID-19 Vaccine.

•             A single booster dose of the Janssen COVID-19 Vaccine may be administered to eligible individuals who have completed primary vaccination with a different authorized or approved COVID-19 vaccine. Please check with your health care provider regarding eligibility for and timing of the booster dose.

WHAT ARE THE RISKS OF THE JANSSEN COVID-19 VACCINE?

جانسن COVID-19 ويڪسين سان گڏ رپورٽ ڪيل ضمني اثرات شامل آهن:

•             Injection site reactions: pain, redness of the skin, and swelling.

•             General side effects: headache, feeling very tired, muscle aches, nausea, fever.

•             Swollen lymph nodes.

•             Blood clots.

•             Unusual feeling in the skin (such as tingling or a crawling feeling) (paresthesia), decreased feeling or sensitivity, especially in the skin (hypoesthesia).

•             Persistent ringing in the ears (tinnitus).

•             Diarrhea, vomiting.

Severe Allergic Reactions

اتي هڪ دور دراز موقعو آهي ته جانسن COVID-19 ويڪسين سخت الرجڪ رد عمل جو سبب بڻجي سگهي ٿي. جانسن COVID-19 ويڪسين جي هڪ دوز حاصل ڪرڻ کان پوءِ هڪ سخت الرجڪ رد عمل عام طور تي چند منٽن کان هڪ ڪلاڪ اندر واقع ٿيندو. ان لاءِ، توهان جو ويڪسينيشن فراهم ڪندڙ شايد توهان کي ان جاءِ تي رهڻ لاءِ چئي سگهي ٿو جتي توهان ويڪسينيشن کان پوءِ نگراني لاءِ توهان جي ويڪسين حاصل ڪئي هئي. سخت الرجڪ ردعمل جي نشانين ۾ شامل ٿي سگھي ٿو:

•             Difficulty breathing

•             Swelling of your face and throat

•             A fast heartbeat

•             A bad rash all over your body

•             Dizziness and weakness

پليٽليٽس جي گھٽ سطح سان رت جا ڪلٽ

رت جا ڦڙا جن ۾ دماغ، ڦڦڙن، پيٽ ۽ پيرن ۾ رت جون شيون شامل هونديون آهن ۽ پليٽليٽس جي گهٽ سطح (رت جا سيل جيڪي توهان جي جسم کي رت وهڻ بند ڪرڻ ۾ مدد ڪندا آهن)، ڪجهه ماڻهن ۾ واقع ٿيا آهن جن کي جانسن COVID-19 ويڪسين ملي آهي. انهن ماڻهن ۾ جيڪي رت جا ڦڙا ۽ پليٽليٽس جي گهٽ سطح کي ترقي ڪري رهيا آهن، علامتون ويڪسينيشن کان لڳ ڀڳ هڪ کان ٻن هفتن کان پوءِ شروع ٿيون. 18 کان 49 سالن جي عمر جي عورتن ۾ انهن رت جي ڦٽن ۽ پليٽليٽس جي گهٽ سطح جي رپورٽ تمام گهڻي آهي. اهو ٿيڻ جو موقعو پري آهي. توهان کي فوري طور تي طبي ڌيان طلب ڪرڻ گهرجي جيڪڏهن توهان کي Janssen COVID-19 ويڪسين حاصل ڪرڻ کان پوءِ هيٺ ڏنل علامتن مان ڪي به آهن:

•             Shortness of breath,

•             Chest pain,

•             Leg swelling,

•             Persistent abdominal pain,

•             Severe or persistent headaches or blurred vision,

•             Easy bruising or tiny blood spots under the skin beyond the site of the injection.

اهي شايد جانسن COVID-19 ويڪسين جا سڀ ممڪن ضمني اثرات نه هجن. سنجيده ۽ غير متوقع اثرات ٿي سگھي ٿو. جانسن COVID-19 ويڪسين اڃا تائين ڪلينڪل تجربن ۾ اڀياس ڪئي پئي وڃي.

Guillain Barré Syndrome

Guillain Barré syndrome (هڪ اعصابي خرابي جنهن ۾ جسم جو مدافعتي نظام اعصاب جي سيلن کي نقصان پهچائيندو آهي، عضلات جي ڪمزوري ۽ ڪڏهن ڪڏهن فالج جو سبب بڻجندو آهي) ڪجهه ماڻهن ۾ ٿي چڪو آهي جن کي جانسن COVID-19 ويڪسين ملي آهي. انهن مان اڪثر ماڻهن ۾، جانسن COVID-42 ويڪسين جي وصولي کانپوءِ 19 ڏينهن اندر علامتون شروع ٿي ويون. اهو ٿيڻ جو امڪان تمام گهٽ آهي. توهان کي فوري طور تي طبي ڌيان طلب ڪرڻ گهرجي جيڪڏهن توهان Janssen COVID-19 ويڪسين حاصل ڪرڻ کان پوءِ هيٺ ڏنل علامتن مان ڪنهن کي پيدا ڪيو:

•             Weakness or tingling sensations, especially in the legs or arms, that’s worsening and spreading to other parts of the body.

•             Difficulty walking.

•             Difficulty with facial movements, including speaking, chewing, or swallowing.

•             Double vision or inability to move eyes.

•             Difficulty with bladder control or bowel function.

WHAT SHOULD I DO ABOUT SIDE EFFECTS?

If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital.

Call the vaccination provider or your healthcare provider if you have any side effects that bother you or do not go away.

Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to vaers.hhs.gov. Please include “Janssen COVID-19 Vaccine EUA” in the first line of box #18 of the report form.  In addition, you can report side effects to Janssen Biotech Inc. at 1-800-565-4008.

CAN I RECEIVE THE JANSSEN COVID-19 VACCINE AT THE SAME TIME AS OTHER VACCINES?

Data have not yet been submitted to FDA on administration of the Janssen COVID-19 Vaccine at the same time as other vaccines. If you are considering receiving the Janssen COVID-19 Vaccine with other vaccines, discuss your options with your healthcare provider.